articleJAMAMar 24, 2020Closed access

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

University of Nebraska Medical Center

PubMed
Indexed incrossrefpubmed

Abstract

Chenguang Shen, PhD; Zhaoqin Wang, PhD; Fang Zhao, PhD; Yang Yang, MD; Jinxiu Li, MD; Jing Yuan, MD; Fuxiang Wang, MD; Delin Li, PhD; Minghui Yang, PhD; Li Xing, MM; Jinli Wei, MM; Haixia Xiao, PhD; Yan Yang, MM; Jiuxin Qu, MD; Ling Qing, MM; Li Chen, MD; Zhixiang Xu, MM; Ling Peng, MM; Yanjie Li, MM; Haixia Zheng, MM; Feng Chen, MM; Kun Huang, MM; Yujing Jiang, MM; Dongjing Liu, MD; Zheng Zhang, MD; Yingxia Liu, MD; Lei Liu, MD

Citation impact

520
total citations
FWCI
163.00
Percentile
100%
References
8
Citations per year

Authors

1

Topics & keywords

Keywords
  • Medicine
  • Coronavirus disease 2019 (COVID-19)
  • Zhàng
  • Pandemic
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • 2019-20 coronavirus outbreak
  • Virology
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.